Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ATORVASTATIN\EZETIMIBE for Cardiovascular event prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 23 adverse event reports in the FDA FAERS database where ATORVASTATIN\EZETIMIBE was used for Cardiovascular event prophylaxis.

Most Reported Side Effects for ATORVASTATIN\EZETIMIBE

Side Effect Reports % Deaths Hosp.
Myalgia 130 10.5% 0 13
Acute kidney injury 60 4.9% 0 47
Pain 45 3.6% 0 24
Pain in extremity 43 3.5% 0 17
Dizziness 42 3.4% 0 16
Malaise 42 3.4% 3 25
Pyrexia 41 3.3% 0 35
Rhabdomyolysis 40 3.2% 1 30
Arthralgia 39 3.2% 0 17
Headache 39 3.2% 0 18
Hepatic cytolysis 39 3.2% 0 24
Dyspnoea 36 2.9% 0 22
Muscle spasms 36 2.9% 0 6
Interstitial lung disease 35 2.8% 2 24
Nausea 35 2.8% 0 19

Other Indications for ATORVASTATIN\EZETIMIBE

Dyslipidaemia (239) Hypercholesterolaemia (202) Product used for unknown indication (152) Hyperlipidaemia (62) Coronary artery disease (46) Type iia hyperlipidaemia (40) Prophylaxis (36) Myocardial infarction (29) Myocardial ischaemia (27) Blood cholesterol (20)

Other Drugs Used for Cardiovascular event prophylaxis

ATORVASTATIN (4,792) LIPITOR (1,863) ASPIRIN (950) ASPIRIN DL-LYSINE (653) CANAKINUMAB (560) RIVAROXABAN (432) CLOPIDOGREL BISULFATE (414) TICAGRELOR (351) SEMAGLUTIDE (207) ICOSAPENT ETHYL (196)

Related Pages

ATORVASTATIN\EZETIMIBE Full Profile All Cardiovascular event prophylaxis Drugs ATORVASTATIN\EZETIMIBE Demographics ATORVASTATIN\EZETIMIBE Timeline